Press Releases For all investor or media inquiries, visit https://www.adaptimmune.com/contact. Year All News | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | Nov 09, 2017 TCR² Therapeutics to Present at the Jefferies 2017 Global Healthcare Conference Nov 02, 2017 TCR² Therapeutics Appoints Cell Therapy Pioneer Dr. Stephan Grupp to Advisory Board Oct 31, 2017 TCR² Therapeutics to Present New Data from its TRuC™ T Cell Programs at the Society for Immunotherapy of Cancer (SITC) Annual Meeting Oct 11, 2017 TCR² Therapeutics Appoints Leading Cell Therapy Expert as Chief Medical Officer Sep 15, 2017 TCR² Therapeutics Named One of the 15 Innovative Immuno-Oncology Biotechs to Watch in 2018 by Immuno-Oncology Frontiers Aug 29, 2017 TCR² Therapeutics to Present Solid Tumor Data at CAR-TCR Summit and CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference Aug 08, 2017 TCR² Therapeutics to Present at the 2017 Wedbush PacGrow Healthcare Conference Jun 13, 2017 TCR² Therapeutics Presents Positive Solid Tumor Data for its Novel TRuC™ Engineered T Cell Therapies at the World Preclinical Congress May 16, 2017 TCR² Therapeutics to Present at the 2017 UBS Global Healthcare Conference Feb 28, 2017 TCR² Therapeutics to Present at the Cowen and Company 37th Annual Health Care Conference